Novartis AG (VIE:NOVN)

Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of EUR 248.55 billion. The enterprise value is 269.56 billion.

Market Cap	248.55B
Enterprise Value	269.56B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.92B
Shares Outstanding	n/a
Shares Change (YoY)	-3.86%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	36.84%
Float	1.83B

Valuation Ratios

The trailing PE ratio is 20.87 and the forward PE ratio is 17.25.

PE Ratio	20.87
Forward PE	17.25
PS Ratio	5.15
PB Ratio	6.27
P/TBV Ratio	n/a
P/FCF Ratio	16.58
P/OCF Ratio	15.24
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.08, with an EV/FCF ratio of 17.99.

EV / Earnings	22.63
EV / Sales	5.50
EV / EBITDA	14.08
EV / EBIT	17.67
EV / FCF	17.99

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.76.

Current Ratio	1.12
Quick Ratio	0.76
Debt / Equity	0.76
Debt / EBITDA	1.60
Debt / FCF	2.02
Interest Coverage	15.42

Financial Efficiency

Return on equity (ROE) is 30.81% and return on invested capital (ROIC) is 21.92%.

Return on Equity (ROE)	30.81%
Return on Assets (ROA)	10.34%
Return on Invested Capital (ROIC)	21.92%
Return on Capital Employed (ROCE)	21.09%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	636,101
Profits Per Employee	156,954
Employee Count	75,883
Asset Turnover	0.53
Inventory Turnover	2.28

Taxes

In the past 12 months, Novartis AG has paid 2.03 billion in taxes.

Income Tax	2.03B
Effective Tax Rate	14.59%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	118.08
200-Day Moving Average	n/a
Relative Strength Index (RSI)	67.95
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of EUR 48.27 billion and earned 11.91 billion in profits. Earnings per share was 6.09.

Revenue	48.27B
Gross Profit	36.60B
Operating Income	15.03B
Pretax Income	13.93B
Net Income	11.91B
EBITDA	18.85B
EBIT	15.03B
Earnings Per Share (EPS)	6.09

Balance Sheet

The company has 9.87 billion in cash and 30.20 billion in debt, with a net cash position of -20.33 billion.

Cash & Cash Equivalents	9.87B
Total Debt	30.20B
Net Cash	-20.33B
Net Cash Per Share	n/a
Equity (Book Value)	39.65B
Book Value Per Share	20.54
Working Capital	2.71B

Cash Flow

In the last 12 months, operating cash flow was 16.30 billion and capital expenditures -1.32 billion, giving a free cash flow of 14.99 billion.

Operating Cash Flow	16.30B
Capital Expenditures	-1.32B
Free Cash Flow	14.99B
FCF Per Share	n/a

Margins

Gross margin is 75.83%, with operating and profit margins of 31.13% and 24.67%.

Gross Margin	75.83%
Operating Margin	31.13%
Pretax Margin	28.85%
Profit Margin	24.67%
EBITDA Margin	39.05%
EBIT Margin	31.13%
FCF Margin	31.05%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	55.91%
Buyback Yield	3.86%
Shareholder Yield	3.86%
Earnings Yield	4.79%
FCF Yield	6.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5